Sprycel for melanoma
Updated: 2010-08-31 08:37:00
A step forward in understanding the BRCA2 ‘cancer gene’
Updated: 2010-08-27 10:49:03
Imagine you’ve entered a contest to cook the world’s biggest ball of spaghetti. You have to meet the following criteria: the ball has to be made of a single spaghetti strand; the strand has to be entwined in a very exact way; and you have to be able to pick up the ball without the [...]More good progress for experimental cancer drug
Updated: 2010-08-26 17:22:31
Last September, we covered results from a small trial of an experimental drug called PLX4032, which has been developed to treat patients whose cancers are caused by a faulty version of a gene called BRAF. Today, yet more encouraging results were announced in the New England Journal of Medicine, which were reported widely in the [...]DNA scan reveals secret of melanoma’s ‘self-healing’ powers
Updated: 2010-08-25 17:52:44
Malignant melanoma – the most dangerous form of skin cancer – is a cunning adversary. Once it has started spreading through the body, the disease is difficult to treat effectively. The cancer cells seem to shrug off the effects of DNA-damaging chemotherapy drugs, repairing themselves, and continuing to multiply as before. As a result, many [...]Palliative care isn’t ‘giving up’ – it improves quality of life and dignity, and maybe even survival
Updated: 2010-08-23 16:52:09
The UK led the world in developing hospices and effective palliative care. People like Dame Cicely Saunders were trailblazers in showing how important it is to make sure that, when people can’t be cured and are approaching the end of their lives, it’s important to focus on the things that make what time they have [...]International drug trials underline the future of cancer treatment
Updated: 2010-08-18 11:56:48
As we reported on our news feed yesterday, two new international trials are reporting yet more benefits from a new experimental cancer drug called olaparib. At Cancer Research UK we’re very optimistic about this drug, which our scientists played a key role in developing. It’s a new type of cancer drug, called a PARP inhibitor, [...]Target Now
Updated: 2010-08-17 11:46:00‘Starvation gene’ could make resistance futile for ovarian cancer cells
Updated: 2010-08-17 10:10:28
Every time a cell divides, its chromosomes go through a country dance. Forming pairs, they line up in a neat row, facing each other, before dramatically shimmying to opposite ends of the room along long ‘spindles’ of protein. Having split its dancing partners, the cell pinches itself in two and separates them forevermore. The spindle [...]From microscope to telescope – how astronomy could help cancer research
Updated: 2010-08-16 11:55:34Scientists at our Cambridge Research Institute have turned their gaze from the lab bench to the stars, teaming up with researchers from the Institute of Astronomy at the University of Cambridge. Writing in The Times (requires payment), science editor Mark Henderson explores this unlikely collaboration, and how it could help cancer patients in the future. [...]Balancing personal responsibility and sensible regulation
Updated: 2010-08-13 17:08:33
In a speech in July, Health Secretary Andrew Lansley signalled to a room full of healthcare professionals how the Coalition Government’s public health policy would differ from that of the previous administration. Gone are the days, he said, of “lecturing and nannying”. Instead, the strategy would be “nudging individuals in the right direction, encouraging positive [...]Confused about what causes breast cancer? Read on
Updated: 2010-08-11 12:39:06
When it comes to what causes breast cancer, the evidence can be confusing. And the constant flow of often conflicting reports in the media does little to help matters. This is why we provided some advice to the Daily Mail for a recent feature on the evidence behind a range of different breast cancer risk [...]Asthma inhaler link to prostate cancer is overblown
Updated: 2010-08-10 17:27:07
Asthmatic men may have been alarmed to read recent headlines claiming a link between inhalers to treat the condition and prostate cancer. But the headlines don’t actually reflect the true story. Fortunately, the excellent NHS Choices Behind the Headlines blog has stepped in to clear up the misinformation. They explain: “This… study has found an [...]Bendamustine, Mitozantrone and Rituxan for lymphoma
Updated: 2010-08-05 18:23:48Cancer During Pregnancy AOL Health
Updated: 2010-08-04 17:50:50AOL MAIL Sign In Register AOL Health Main Diseases Conditions ADHD Mens Sexual Health Allergies Obesity Alzheimer's Plastic Surgery Breast Cancer Skin Conditions Cancer Sleep Disorders Cold and Flu Smoking Cessation Diabetes Stroke Depression Stomach Pain Eye Care Women's Sexual Health Heart Disease See All Conditions Family Health Caregiver Support Senior's Health Children's Health Teen Health Men's Health Women's Health Healthy Living Anti Aging Memory Beauty Skincare Relationships Better Body Better Living Sleep Health Dental Health Stress Healthy Eating 30 Days to a Better You Diet Fitness America Takes it Off Experts Celebrity Fitness Diet Success Motivation Drugs Browse Drugs and Supplements Tools BMI Calculator Symptom Checker Compare Medicare Plans Veggie Fruit Tracker DrugDacogen maintenance in AML
Updated: 2010-08-04 01:49:26: Cancer Treatment Vidaza Maintenance in AML Main Dacogen maintenance in AML Dacogen decitabine is a new drug , a DNA methyltransferase inhibitors DMTI that approved by the FDA for use in all French- American British FAB categories for MDS . This drug is now FDA approved for . MDS For acute myelogenous leukemia AML less is known . A 2007 review , looked at 33 patients with the World Health Organization WHO criteria of AML that were treated with decitabine alone 23 patients or in combination with valproic acid 10 patients as first-line therapy . There were 20 men 61 and their median age was 72, range 39 to 85. Median bone marrow blasts at study entry was 26 and 14 42 had 30 blasts . There were three different schedules of decitabine IV , which gave a total of 100–150 mg m2 course over 3–10Vidaza Maintenance in AML
Updated: 2010-08-04 01:44:40